Related Experiment Video
Updated: Jul 16, 2025

02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
5.3K
Towards precision pain management-the case for targeting DRP1 in remifentanil-induced hyperalgesia
1Department of Anesthesiology and Pain Medicine, Chosun University Hospital, School of Medicine and Medical College, Chosun University, Gwangju, Korea.
The Korean Journal of Pain
|September 18, 2023
Abstract
No abstract available in PubMed .
Related Concept Videos
Analgesia and Pain Management
652
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
652
Opioid Analgesics: Synthetic and Semisynthetic Opioids
331
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
331

